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ABSTRACT: The LCModel method was adapted to analyze localized in vivo 13C NMR spectra obtained from the rat brain
in vivo at 9.4 T. Prior knowledge of chemical-shifts, J-coupling constants and J-evolution was included in the analysis. Up to
50 different isotopomer signals corresponding to 10 metabolites were quantified simultaneously in 400 ml volumes in the rat
brain in vivo during infusion of [1,6-13C2]glucose. The analysis remained accurate even at low signal-to-noise ratio of the
order of 3:1. The relative distribution of isotopomers in glutamate, glutamine and aspartate determined in vivo in 22 min was
in excellent agreement with that measured in brain extracts. Quantitation of time series of 13C spectra yielded time courses
of total 13C label incorporation into up to 16 carbon positions, as well as time courses of individual isotopomer signals, with
a temporal resolution as low as 5 min (dynamic isotopomer analysis). The possibility of measuring in vivo a wealth of
information that was hitherto accessible only in extracts is likely to expand the scope of metabolic studies in the intact brain.
Copyright # 2003 John Wiley & Sons, Ltd.
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INTRODUCTION
In vivo 13C NMR spectroscopy combined with the ad-
ministration of 13C-enriched substrates is a unique tool to
investigate brain metabolism. The high chemical specifi-
city of 13C NMR, which can distinguish 13C isotope
incorporation not only into different molecules, but also
into specific carbon positions within the same molecule
(13C isotopomers), allows the fate of 13C label to be
followed through multiple metabolic pathways.1 In con-
trast to studies performed on brain extracts, where the
multiplet structure of 13C NMR resonances caused by
13C–13C scalar couplings was exploited,2 the amount of
information accessible in the brain in vivo has been
limited by the lower signal-to-noise ratio and the lower
spectral resolution of in vivo spectra.
Recent improvements in direct, localized 13C NMR
spectroscopy have considerably expanded the amount of
information that can be obtained in vivo in the human
brain3–7 and in the rat brain.8–10 The availability of higher
field magnets, the use of automated shimming proce-
dures11 and more efficient second-order shim coils, and
the development of new pulse sequences for localized
detection3,6,8,9 have led to substantial gains in sensitivity,
spectral resolution and localization performance (see also
the review by Gruetter et al. in this issue). Broadband 1H-
localized 13C spectra obtained recently from the rat brain
at 9.4 T during an infusion of 13C-labeled glucose have
allowed the detection of 13C NMR signals from 18
different carbon positions, ranging from the alanine C3
resonance at 17 ppm to the glucose C1 resonance at
96.8 ppm.8 In addition, the fine structure arising from
13C–13C J-couplings became detectable not only in
glutamate,4,9 but in several other metabolites, suggesting
that numerous isotopomers could be measured in the
brain in vivo with a temporal resolution suitable for
dynamic isotopomer analysis.
Quantitative analysis of in vivo 13C spectra has tradi-
tionally been performed using manual peak integration or
peak fitting of individual resonances.10,12,13 This ap-
proach, although user-dependent and time-consuming,
is often adequate because in vivo 13C NMR spectra are
typically characterized by a high spectral dispersion and a
flat baseline (provided that lipid signals coming from the
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scalp are properly eliminated, either by spatial localiza-
tion of NMR signals, or by subtraction of a natural
abundance background spectrum acquired before infu-
sion of 13C-labeled substrate). However, even with ex-
cellent shimming and spatial localization of NMR
signals, quantitation of multiplets arising from different
13C isotopomers remains challenging in the brain in vivo
because of the low signal-to-noise ratio and because the
linewidth of 13C singlets (typically 5–10 Hz depending on
B0 field strength and shimming) is not negligible com-
pared with homonuclear 13C–13C J-coupling values (30–
50 Hz), leading to significant overlap of multiplets within
a given carbon resonance.
Incorporation of prior knowledge has been shown to
improve the precision of spectral analysis, especially in the
presence of spectral overlap.14–16 Of the numerous meth-
ods that have been proposed to analyze NMR spectra,
either in the time domain17 or in the frequency domain,18
several have the capability to incorporate prior knowl-
edge.19–23 Prior knowledge has been used to quantify, for
example, 13C–13C multiplets from tissue extracts,24–27
2H–13C multiplets from cell suspensions,19 in vivo 13C
spectra from muscle28 or C1-glycogen and C1-glucose
signals in 13C spectra from perfused liver,29 but to the best
of our knowledge such an approach has not been reported
for quantitation of 13C isotopomers in the brain in vivo.
LCModel23 (linear combination of model spectra) has
become increasingly popular to quantify in vivo 1H NMR
spectra (for a recent review see Provencher30) and has
been used extensively in our laboratory.31–33 LCModel
has several attractive features for analysis of in vivo
spectra: a model-free lineshape, a high degree of flex-
ibility in the introduction of prior knowledge, and robust-
ness in cases of low signal-to-noise ratio and spectral
overlap. Furthermore, the program is fully automatic,
another advantage for processing time series of 13C
spectra. However, because LCModel was originally de-
signed for the analysis of 1H spectra, specific assumptions
were made regarding the information content of the data
to be fitted, such as the presence of substantial singlet
signals (e.g. NAA or Cr) in the spectrum for the pre-
liminary determination of lineshape, as well as a small
spectral range (a few ppm). These and other assumptions
required significant adjustments in order to apply the
original LCModel program to in vivo 13C NMR spectra.
The purpose of this work was (1) to adapt LCModel for
the analysis of in vivo 13C NMR spectra using prior
knowledge, and (2) to evaluate the feasibility and robust-
ness of dynamic 13C isotopomers analysis in the rat brain
in vivo.
MATERIALS AND METHODS
Animal preparation
All animal experiments were performed in accordance
with the guidelines for the care and use of laboratory
animals and were approved by the Institutional Animal
Care and Use Committee of the University of Minnesota.
Male Sprague–Dawley rats (n¼ 5; weight 273 23 g,
mean SD) (Harlan, Indianapolis, IN, USA) were in-
tubated and ventilated with a 70%:30% N2O–O2 mixture
and 3% isoflurane. Both femoral veins were cannulated
for the i.v. administration of glucose and -chloralose,
and both arteries were cannulated for blood sampling
to monitor blood gases and plasma glucose concen-
trations. Immediately after surgery, isoflurane was dis-
continued and replaced by intravenous -chloralose
administration (bolus 40 mg/kg, then continuous infu-
sion at 25.4 mg/kg/h). Animals were placed prone in a
home-built holder and the head position was fixed using
ear rods and a bite-bar. After adjustment of NMR
parameters, a bolus of 99%-enriched [1,6-13C2]glucose
(Cambridge Isotope Laboratories) was administered
over 5 min with an infusion rate decaying exponentially
every minute. This bolus was followed by a continuous
infusion of 70%-enriched glucose for the remaining 7 h
of the experiment. Small adjustments were made to the
rate of continuous infusion to keep plasma glucose
around 300 mg/dl. This protocol was optimized to
achieve a stable plateau in plasma glucose isotopic
enrichment.34
In vivo 13C NMR spectroscopy
All in vivo spectra were acquired on a 9.4 T/31 cm bore
magnet (Magnex Scientific, Oxford, UK) interfaced to an
Inova console (Varian, Palo Alto, CA, USA). The magnet
was equipped with gradients reaching 300 mT/m in
500ms and with a set of custom-designed second-order
shim coils capable of producing shim strengths up to
0.05 mT/cm2 (Magnex Scientific, Oxford, UK). The coil
assembly consisted of a 1H quadrature surface coil (two
loops of 14 mm diameter) and an inner 13C linearly
polarized surface coil (12 mm diameter) built according
to a previously described design.35 Spin-echo RARE
images were acquired to select a 9 5 9 mm3 volume
in the rat brain. Adjustment of all first and second-order
shims using FAST(EST)MAP11 resulted in an 18–23 Hz
water linewidth in the 400 ml voxel. Localized in vivo 13C
NMR spectra were acquired with a semi-adiabatic DEPT
sequence as described elsewhere.8 Briefly, localization
was performed on the 1H magnetization using 3D-ISIS
combined with outer volume saturation (OVS). Magne-
tization was then transferred to 13C using gradient-
spoiled semi-adiabatic DEPT polarization transfer. The
interpulse delay was 3.8 ms (optimized for JCH¼
130 Hz) and the nominal flip angle of the last 1H pulse
was set to 45 in order to detect signals from CH, CH2
and CH3 groups simultaneously. Repetition time was
2.5 s. WALTZ-16 composite pulse decoupling was ap-
plied during the acquisition time (205 ms, 8192 complex
points) with a nominal B1/2 of 2 kHz.
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13C NMR spectroscopy of brain extracts
At the end of the in vivo measurements, brains were
funnel-frozen in situ with liquid nitrogen36,37 as follows.
Animals were deeply anesthetized with an i.v. bolus of
pentobarbital (25 mg/kg) and the scalp was quickly
retracted. A funnel was applied directly on the skull
and application of liquid nitrogen resulted in frozen brain
within 2 min, at which point the animals were decapi-
tated. A final blood sample was taken 1 min after starting
funnel-freezing to ensure that mechanical ventilation
maintained adequate blood oxygenation. The brain was
dissected out of the skull under intermittent liquid nitro-
gen to minimize post-mortem metabolism. Brain tissue
was crushed in a mortar and pestle and extracted with
5 ml ice-cold perchloric acid (0.9 M). Samples were
centrifuged for 15 min at 4C and the supernatant was
neutralized with 9 M KOH. After another 15 min centri-
fugation, supernatants were freeze-dried and resuspended
in 10% D2O–90% H2O and pH was adjusted to
7.15 0.05 (range 7.1–7.2; n¼ 5) by titration with 1 M
HCl or 1 M NaOH. This pH was close to pH values
reported in the rat brain.38 The effect of 10% D2O on
measurements of pH using a glass electrode was shown to
be less than 0.04 pH units.39
Perchloric acid extracts of brain tissue were mea-
sured using high-resolution 13C NMR spectroscopy
on a 14.1 T Varian Unity Inova spectrometer. One-
dimensional pulse-acquire 13C spectra were acquired
with NOE under fully relaxed conditions (TR¼ 15 s,
spectral width 30 000 Hz, acquisition time 1 s, with
WALTZ-16 decoupling). All resonances were fitted using
built-in spectrometer software after zero-filling to 512 K
points. Resonance frequencies measured in spectra from
five different animals were used to determine mean
chemical-shifts and J-coupling values. Assignment of
resonances was based on peak position using published
values24,41–43 (Rogers Magnetic Resonance Center http://
www2.utsouthwestern.edu/rogersmr/chemical_shifts.htm;
W. Wilker, http://alf.zfn.uni-bremen.de/wie/ww_metab.
html) and on relative signal intensity. All chemical-shift
values were referenced to lactate at 21 ppm.
LCModel data processing
In vivo spectra were processed using a modified version
of LCModel 2.3 (Stephen Provencher Inc., Oakville,
Ontario, Canada). Input files for LCModel were generated
automatically using Matlab (The MathWorks Inc., Natick,
MA, USA). FIDs were preprocessed to place the center of
the spectral window at 4.65 ppm by applying a linear
phase shift in the time domain after removing the DC
offset. No other baseline correction, zero-filling or time-
domain filtering was applied prior to LCModel analysis.
Because LCModel was initially designed to analyze 1H
spectra, significant changes had to be made in the input
parameters in the CONTROL input file (see Appendix for
the most important parameters). Spectra were processed
using a Sun Blade 2000 64-bit workstation (Sun Micro-
systems, Santa Clara, CA, USA) equipped with two
900 MHz copper processors. The typical time required
for analysis of one broadband 13C spectrum was 4 min.
The basis set for LCModel was generated using Matlab
by simulating each isotopomer with the appropriate che-
mical-shift and J-coupling pattern (based on the values
measured in this study). For isotopomers labeled at more
than one carbon, homonuclear 13C–13C J-modulation
occurring during the delay 2* [where  ¼ 1/(2*JCH) and
JCH¼ 130 Hz] between 13C excitation (i.e. the first seg-
ment of the BIR-4 pulse) and acquisition in the DEPT
sequence was taken into account by simulating the corre-
sponding phase distortion of the multiplet spectrum as-
suming weak coupling conditions. For example, the triplet
of glutamate C3 at 27.84 ppm was simulated as the sum of
three lines with relative intensities 1:2:1, relative frequen-
cies -JCC:0:JCC (in this case JCC¼ 34.6 Hz) and relative
phases 0:0:-0 with 0¼ 2**JCC radians. The delay 
used to calculate 0 was empirically set to 2.75 ms, which
was shorter than 1/(2*JCH), because
13C–13C J-modulation
was reduced during the high B1 part of the segmented BIR-
4 pulse (2 ms total duration). In cases where one of the two
coupled carbons belonged to a carboxyl group (COOH), J-
modulation was neglected because carboxyl carbon reso-
nances (e.g. the C1 of glutamate at 175 ppm) were not
inverted by the middle segment of the BIR-4 pulse. In all
cases the lineshape for the basis set was Lorentzian with
4 Hz full-width at half-maximum. In addition, a small
singlet was added at 0 ppm in all basis spectra for auto-
matic frequency referencing. About 50 different isotopo-
mer resonances were included in the basis set, as listed in
Table 1. Relative concentrations determined by LCModel
were converted into absolute concentrations (in mmol/g
wet weight) using the fractional enrichment of glutamate
C4 measured on extracts and assuming a glutamate con-
centration of 10mmol/g. Correction factors were applied to
account for differences in polarization transfer efficiency
and off-resonance effects across the 13C spectrum.
Notation
The notation adopted here for 13C multiplets was similar
to that used by Jeffrey et al.26 A specific multiplet was
designated by an abbreviation of the metabolite name,
followed by the specific carbon resonance observed, then
by a letter denoting the multiplet structure (S¼ singlet,
D¼ doublet, T¼ triplet, DD¼ doublet of doublet). For
example, Glu-C3S and Glu-C3T designated the singlet
and the triplet of glutamate at the C3 position. To indicate
the total amount of 13C label at a specific carbon position,
the resonance name was used without any additional
letter. Thus Glu-C3 referred to the sum of all glutamate
isotopomers labeled at the C3 position. In some cases it
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was necessary to further specify which doublet was
considered by adding two numbers to indicate the J-
coupling. For example, Glu-C2D21 and Glu-C2D23
designated two different doublets at the C2 position,
one corresponding to the coupling to the C1, the other
to the coupling to the C3. When the coupling constants
were identical, no numbers were added. Therefore Glu-
C3D actually was the sum of Glu-C3D32 and Glu-
C3D34. Note that a given multiplet can represent the
sum of different 13C isotopomers. For example, Glu-
C3T¼ [2,3,4-13C3]glutamateþ[1,2,3,4-13C4]glutamateþ
ateþ [2,3,4,5-13C4]glutamate. Long-range couplings are
small (typically 1 Hz for two-bond couplings and 2–3 Hz
for three-bond couplings44) compared with the linewidth
of 13C resonances observed in vivo, and their effect on
linewidth and lineshape was assessed to be negligible in
this study.
Stastistics
Signal-to-noise ratios were calculated as the peak height
divided by twice the root mean square noise. All results
are provided as mean SD.
RESULTS
In vivo 13C NMR spectra obtained from the rat brain at
9.4 T contained a considerable amount of information
[Fig. 1(a)] as in our previous study.8 Resonances from
glucose C1, glucose C6, glutamate C4, C3, C2, glutamine
C4, C3, C2 and aspartate C3, C2 were detected, as well as
smaller resonances from GABA, NAA and lactate. In
vivo spectra were in appearance very similar to appro-
priately line-broadened spectra obtained from brain ex-
tracts [Fig. 1(b)]. The funnel-freezing procedure resulted
in relatively high brain glucose and low lactate concen-
trations detected in 13C spectra of brain extracts.
Chemical shifts and homonuclear J-coupling constants
were measured in extract spectra obtained from five
different animals after 7 h of [1,6-13C2]glucose infusion
(Fig. 2). Multiplets were detected for glucose C1, glucose
C6, glutamate and glutamine C2, NAA and aspartate C2,
GABA C4 and NAA C3, aspartate C3, GABA C2 and
glutamate C4, glutamine C4, glutamate and glutamine
C3, and GABA C3. These multiplets were in general the
superposition of spectral contributions from different
isotopomers. For example, the multiplet corresponding
to the glutamate C3 resonance at 27.85 ppm was the sum
of a singlet Glu-C3S, a doublet Glu-C3D (corresponding
Figure 1. Comparison of 13C NMR spectra acquired in vivo and from brain extracts: (a) 1H-localized 13C spectrum acquired
from the rat brain (400ml) 3 h after starting an infusion of [1,6-13C2]glucose (5120 scans, TR 2.5s); (b) High-resolution
13C
spectrum from a perchloric acid extract of brain tissue acquired at 150 MHz (256 scans, TR 15 s, with NOE enhancement).
Minimal post-mortem degradation was present, as judged from the high glucose C6 signal and the low lactate C3 signal. The
extract spectrum was line-broadened (8 Hz Lorentzian line broadening) to match the linewidth of the processed in vivo
spectrum (3 Hz line broadening). The lower intensity of glucose C1 on the in vivo spectrum is due to off-resonance effects
of the pulse sequence. Note the phase distortion of 13C–13C multiplets in vivo, especially visible for glutamate C3 around
27.9 ppm, due to 13C–13C J-modulation
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Figure 2. Expansions of regions from a high-resolution 13C spectrum of extracted rat brain tissue showing multiplets
corresponding to 13C-labeled isotopomers: (a) glucose C1; (b) glucose C6; (c) glutamate and glutamine C2; (d) NAA
and aspartate C2; (e) NAA C3 and GABA C4; (f) aspartate C3; (g) GABA C2 and glutamate C4; (h) glutamine C4 and
GSH-Glu C4; (i) glutamate and glutamine C3; (j) GABA C3. Spectrum was acquired at 600 MHz (2048 scans, TR 15 s,
with NOE enhancement, spectral width 30 000 Hz, acquisition time 1 s). A small gaussian filtering was applied (0.3 Hz).
The spectrum was acquired under in vivo conditions (pH¼7.15, T¼37C)
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to Glu-C3D34þGlu-C3D32) and a triplet Glu-C3T [Fig.
2(i)]. The resonance frequencies of these individual
components were slightly different due to isotope effects
on nuclear shielding.45 Chemical shifts were determined
from extract spectra with a precision of 0.01 ppm
(Table 1), and J-coupling values were determined with
a precision below 1% (Table 2). Based on this prior
knowledge of chemical-shifts and J-coupling constants,
model spectra were simulated for the 50 most abundant
isotopomers present in the brain after [1,6-13C2]glucose
infusion. The simulation included the effect of homo-
nuclear 13C–13C J-evolution during DEPT as described in
the Methods.
The LCModel fit of 13C spectra using this simulated
basis set closely matched the in vivo data, as indicated by
the flat residuals (Fig. 3). Even though 13C–13C multiplets
were only partially resolved, the presence of multiple
isotopomers was clearly observed in vivo. The glutamate
C4 resonance was represented by a combination of a
Table 1. Mean chemical shifts values measured in 13C
NMR spectra of brain extracts from five different
animals. Spectra were acquired at 150 MHz under
physiological conditions (pH¼ 7.15, T¼37C). All che-
mical shifts were referenced to lactate at 21 ppm
Resonance Multiplet Mean (ppm) SD (ppm)
(n¼ 5) (n¼ 5)
Ala-C3 S 17.13 0.003
Lac-C3 S 21.00 0.000
NAA-C6 (CH3) S 22.92 0.001
GABA-C3 T 24.51 0.002
D 24.52 0.002
S 24.53 0.002
Gln-C3 T 27.18 0.012
D 27.19 0.012
S 27.20 0.012
Glu-C3 T 27.84 0.005
D 27.85 0.005
S 27.86 0.005
Gln-C4 D43 31.78 0.003
S 31.79 0.003
Glu-C4 D43 34.36 0.004
S 34.37 0.004
GABA-C2 D23 35.23 0.002
S 35.24 0.002
Asp-C3 DD 37.46 0.005
D32 37.46 0.006
D34 37.47 0.006
S 37.48 0.006
Cr-CH3 S 37.81 0.000
GABA-C4 D43 40.43 0.002
S 40.44 0.003
NAA-C3 D 40.56 0.003
S 40.57 0.003
Asp-C2 DD 53.23 0.003
D23 53.24 0.003
D21 53.24 0.004
S 53.24 0.003
NAA-C2 D23 54.11 0.003
S 54.11 0.003
Cr-CH2 S 54.75 0.001
Gln-C2 DD 55.19 0.005
D21 55.19 0.005
D23 55.20 0.005
S 55.20 0.005
Glu-C2 DD 55.69 0.004
D23 55.70 0.004
D21 55.70 0.004
S 55.71 0.004
Serine-C3a S 61.25 0.012
Glc-C6 S,D16 61.57 0.002
Glc-C6 S,D16 61.71 0.002
Myo-Ins C1,C3 S 72.08 0.002
Myo-Ins C2 S 73.13 0.001
Myo-Ins C4,C6 S 73.38 0.002
Myo-Ins C5 S 75.29 0.002
Glc-C1 S,D16 93.00 0.001
Glc-C1 S,D16 96.81 0.001
NAA-C5 (C—O)b S,D 174.31 0.005
Gln-C1b S,D 174.93 0.019
Asp-C1b S,D 175.06 0.006
Glu-C1b S,D 175.38 0.007
Asp-C4b S,D 178.35 0.005
Gln-C5b S,D 178.55 0.007
NAA-C1b S,D 179.49 0.004
NAA-C4b S,D 179.70 0.002
Glu-C5b S,D 182.04 0.004
a Assignment tentative.
b Chemical shifts of carbons in carboxyl groups provided as a
reference but not included in the basis set for LCModel.
Figure 3. LCModel fit of an in vivo 13C NMR spectrum. (a)
1H-localized 13C spectrum acquired in vivo from the rat brain
5 h after starting an infusion of [1,6-13C2]glucose (2816
scans, TR 2.5 s) (b) Fit obtained with LCModel using prior
knowledge of chemical shifts and J-coupling values and (c)
residuals. Only the expansion from 22 to 63 ppm is shown
Table 2. Mean J-coupling values measured in 13C NMR
spectra of brain extracts from five different animals.
Spectra were acquired at 150 MHz under physiological
conditions (pH¼ 7.15, T¼37C)
Metabolite Coupling Mean (Hz) SD (Hz)
Glutamate J12 53.4 0.05
J34, J32 34.6 0.05
J45 51.3 0.2
Glutamine J12 53.4 0.17
J34, J32 34.9 0.09
J45 48.4 0.24
GABA J34, J32 35.1 0.38
Aspartate J12 53.8 0.22
J23 36.4 0.15
J34 50.8 0.08
NAA J12 54.7 0.13
J23 36.3 0.22
J34 51.6 0.05
J56 50.1 0.10
Glucose J16 4.1 0.02
J16 3.3 0.04
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singlet (S) and a doublet (D43) and the glutamate C3
resonance consistently contained a singlet (S), a doublet
(D) and a triplet (T) resonance [Fig. 4(a)]. For glutamate
C2 and glutamine C2, spectral contributions of glutamate
and glutamine isotopomers (S, D23, D21, DD) were
discernible with some spectral overlap between the outer-
most multiplet resonances even at 9.4 T [Fig. 4(b)].
LCModel analysis allowed determination of the contri-
bution of each individual component to the in vivo
spectrum.
To assess the reliability and robustness of the in vivo
isotopomer distribution using LCModel a Monte-Carlo
simulation was performed using different levels of signal
to rms noise ratios. These analyses showed that the
determination of isotopomer concentrations remained
unbiased even at signal-to-noise levels as low as 3:1
(Fig. 5). At very low sensitivity, systematic errors were
apparent, but the total signal (sum of all isotopomers at a
given carbon position) remained more accurate than the
estimation of individual isotopomers contributions. For
example, for a signal-to-noise ratio of 1, the singlet
GluC4S was biased by 50%, but the total glutamate C4
signal (gluC4SþgluC4D43) deviated from the nominal
value by only 15% on average (Fig. 5). Similar observa-
tions (not shown) were made using Monte-Carlo simula-
tions of other multiplet structures, e.g. singletþ
doubletþtriplet (such as glutamate C3) or singletþ dou-
blet1þdoublet2þquartet (such as glutamate C2).
In vivo isotopomer analysis of glutamate, glutamine
and aspartate using LCModel was in excellent agreement
with isotopomer analysis of brain extracts from the same
animal (Table 3). Comparison of the in vivo measurement
obtained immediately before funnel-freezing with the
extract measurement gave a Pearson correlation
coefficient of 0.96 ( p< 0.001) and a slope of 1.1 0.07
(Fig. 6), which was not significantly different from
identity. Isotopomer analysis in NAA C2 and C3 and
GABA C2, C3, C4 was similarly reliable when averaged
over longer time periods to improve sensitivity (not
shown).
The sensitivity of the experiment and concomitant
LCModel analysis indicated that the precision was suffi-
cient to allow a temporally resolved measurement of
singly and multiply labelled isotopomers in vivo. For
example, the singlet Glu-C4S and the doublet Glu-
C4D43 were measured independently with a temporal
resolution of approximately 5 min [Fig. 7(A)]. The total
concentration of glutamate labeled at the C4 position was
obtained as the sum of these two different isotopomers
(Glu-C4¼Glu-C4SþGlu-C4D43). The time course of
Glu-C4D43 directly reflects the time course of 13C
isotopic enrichment at the C3 position, as was shown in
the heart.46 Consistent with this, the time course of Glu-
C4D43/Glu-C4 and the time course of total glutamate C3
(obtained as the sum Glu-C3SþGlu-C3DþGlu-C3T)
were identical within experimental error [Fig. 7(b)].
The multiplets corresponding to glutamate labeled at
the C5 position, possibly due to pyruvate recy-
cling,24,25,47 were not included in the basis set, because
of their low intensity which was assessed in two animals
from the C4D45 and C4DD isotopomers to be 3% after
7 h of 13C-labeled glucose infusion [Fig. 2(g)].
Quantitation of time series of in vivo broadband loca-
lized 13C spectra using LCModel resulted in the simulta-
neous measurement of glutamate C4, C3, C2 and
glutamine C4, C3, C2 in a 400ml volume with a temporal
resolution of 5.4 min (Fig. 8). The standard deviation of
time courses at isotopic steady-state was approximately
Figure 4. Expansions of Fig. 3 showing the fitting of
individual isotopomers in glutamate and glutamine: (a)
Isotopomer analysis of glutamate and glutamine C4 and
C3; (b) isotopomer analysis of glutamate and glutamine C2.
Vertical dashed lines indicate the presence of individual
isotopomers in the in vivo spectrum
Figure 5. Effect of different signal-to-noise ratios on the
determination of isotopomers. Shown is the result of a
Monte-Carlo simulation of noise superimposed on a syn-
thetic glutamate C4 triplet (composed of a singlet C4S and a
doublet C4D43 with 1:1 ratio in signal integral, correspond-
ing to a 50% isotopic enrichment at the C3 position), with
Lorentzian lines of 8 Hz linewidth. Each point represents the
result of 50 fits with a given signal-to-noise ratio (x-axis),
defined as (peak height of GluC4S)/(2*rms noise)
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0.2mmol/g at 5 min time resolution and 0.1mmol/g at
22 min time resolution. In addition, the incorporation of
13C label into glutamate C1 was measured indirectly from
the corresponding isotopomers of glutamate C2, i.e. Glu-
C2D21þGlu-C2DD, with a temporal resolution of
22 min [Fig. 8(b)]. The labeling time course of glutamate
C1 was markedly slower than the labeling of other carbon
positions, because labeling of glutamate C1 from
[1,6-13C2]glucose requires
13C label to pass twice
through the TCA cycle.
DISCUSSION
The present study demonstrates that dynamic 13C iso-
topomer analysis is feasible in the rat brain in vivo.
LCModel fitting with prior knowledge of chemical-shift
and J-coupling values, in conjunction with recent
improvements in sensitivity and resolution of 13C NMR
spectra,8 allowed the simultaneous quantitation of up to
50 different 13C-labeled isotopomer signals correspond-
ing to 10 metabolites in the rat brain. This provides
information that was hitherto accessible only in brain
extracts.
The analysis of 13C NMR spectra with LCModel
required significant adaptations of the program, which
was originally designed to quantify 1H spectra. These
adaptations were necessary to accommodate the specific
characteristics of 13C spectra, such as the broad spectral
range and the absence of strong singlet resonances for the
determination of lineshape (see Appendix). The original
LCModel method was based on the measurement of
model spectra for all spin systems potentially contribut-
ing to the in vivo spectrum. For 13C NMR spectra
acquired during infusion of a 13C-labeled substrate, the
appearance of specific isotopomers requires the
Table 3. Comparison of isotopomers distribution measured in vivo and in extracts for glutamate, glutamine and
aspartate. In vivo spectra were acquired at isotopic steady state immediately before funnel-freezing to allow
comparison with extract spectra. The first columns give the concentration, SD, coefficient of variation, mean
Cramer–Rao bound (CRB) and relative isotopomer distribution determined from five consecutive in vivo spectra
from one animal (22 min each) using LCModel analysis. The last column gives the relative isotopomer distribution
measured in extracts spectra from the same animal
Isotopomer Isotopomer
Mean concentration SD CV Mean CRB (in vivo 22 min) (extracts)
Isotopomer (mmol/g) (mmol/g) (%) (%) (%) (%)
Glu-C4S 2.76 0.08 3 3 53 48
Glu-C4D43 2.44 0.11 4 4 47 52
Glu-C4 total 5.20 0.18 3 2 100 100
Glu-C3S 0.57 0.15 27 24 12 18
Glu-C3D 2.31 0.10 4 5 48 49
Glu-C3T 1.93 0.15 8 10 40 33
Glu-C3 total 4.81 0.08 2 2 100 100
Glu-C2S 2.12 0.09 4 5 40 36
Glu-C2D23 1.99 0.12 6 7 38 37
Glu-C2D21 0.33 0.14 43 52 6 12
Glu-C2DD 0.85 0.18 21 28 16 15
Glu-C2 total 5.29 0.25 5 4 100 100
Gln-C4S 1.36 0.07 5 6 63 58
Gln-C4D43 0.79 0.06 7 12 37 42
Gln-C4 total 2.14 0.05 2 4 100 100
Gln-C3S 0.40 0.06 16 28 19 24
Gln-C3D 0.92 0.11 12 11 43 48
Gln-C3T 0.80 0.26 32 24 38 28
Gln-C3 total 2.12 0.22 10 6 100 100
Gln-C2S 1.32 0.06 5 7 52 51
Gln-C2D23 0.79 0.13 16 18 31 31
Gln-C2D21 0.16 0.11 71 145 6 9
Gln-C2DD 0.27 0.23 84 291 11 9
Gln-C2 total 2.54 0.19 8 9 100 100
Asp-C2S 0.51 0.07 15 17 37 35
Asp-C2D23 0.63 0.07 11 20 47 41
Asp-C2D21 0.00 0.00 0 999 0 10
Asp-C2DD 0.22 0.09 43 94 16 14
Asp-C2 total 1.35 0.14 10 13 100 100
Asp-C3S 0.62 0.06 10 11 42 34
Asp-C3D32 0.60 0.12 21 17 40 40
Asp-C3D34 0.08 0.07 86 307 5 11
Asp-C3DD 0.19 0.21 110 281 13 15
Asp-C3 total 1.48 0.18 12 10 100 100
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individual fit of each isotopomer signal to the spectrum,
which would result in the tedious measurement of ex-
tremely expensive compounds, such as [3,4-13C2]gluta-
mate. However, in the present study, it was possible to
simulate the spectral pattern for each isotopomer, pro-
vided that J-couplings and chemical shifts were accu-
rately measured.
Prior knowledge for simulating the basis set was
obtained by measuring chemical-shifts and J-coupling
constants in five animals under close to physiological
conditions to minimize possible differential effects of pH
and temperature on 13C resonances in extracts compared
to in vivo. Overall, the values in the present study (Tables
1 and 2) were in good agreement with previously pub-
lished values.24,41–43 Small differences were most likely
due to differences in pH and temperature conditions used
to acquire extract 13C spectra. Interestingly, even though
funnel-freezing was used in this study to minimize post-
mortem changes, all three detected resonances of GABA
(at 24.5, 35.2 and 40.4 ppm) were still noticeably higher
in extracts than in vivo, consistent with other observations
of a rapid increase of GABA concentration post-mor-
tem.48 This suggests that GABA levels may change even
more quickly than lactate and glucose concentrations
post-mortem. This was supported by comparing the
present data with preliminary data obtained following
focused microwave fixation of brain within 1.4 s (unpub-
lished observation), where total tissue GABA levels were
lower than with funnel-freezing.
In the present study, an information content was
achieved reminiscent to what had been previously ob-
tained only in spectra of brain extracts. For example, the
isotopomer distribution was determined for glutamate
C4, C3, C2, glutamine C4, C3, C2 as well as aspartate
C3, C2 with a temporal resolution sufficient for dynamic
isotopomer analysis. Overall, the relative contributions
of isotopomers to the total signal determined in vivo
with LCModel were in excellent agreement with the
isotopomer distribution measured in brain extracts
(Table 3) as judged from the overlap of the data points
with the identity line (Fig. 6). This determination of
isotopomer distribution was very robust, even when the
signal-to-noise ratio approached 3:1. To deter-
mine the isotopomer distribution in NAA and GABA
required averaging data for longer time periods. The
Cramer–Rao lower bounds returned by LCModel were
very close to the coefficients of variation measured by
analyzing time series of 13C spectra at isotopic steady
state (Table 3).
The combination of FASTMAP shimming, strong
second-order shim coils, and efficient spatial localization
allowed consistent detection of 13C–13C couplings in the
Figure 7. In vivo time courses of individual isotopomers
(mmol/g of 13C label) during an infusion of [1,6-13C2]glucose:
(a) Time course of Glu-C4S (solid diamonds), Glu-C4D43
(open diamonds) and total Glu-C4 (¼Glu-C4SþGlu-C4D43;
open squares) with a time resolution of 5 min (128 scans,
TR 2.5 s); (b) comparison of C3 labeling measured directly at
the C3 position (Glu-C3¼Glu-C3SþGlu-C3DþGlu-C3T; so-
lid diamonds, left scale) or indirectly through the relative
amount of doublet intensity (Glu-C4D43/Glu-C4tot) at the
C4 position (open diamonds, right scale) with a time resolu-
tion of 22 min. Time courses were obtained by fitting 13C
NMR spectra sequentially with LCModel
Figure 6. Correlation between relative isotopomer distribu-
tion measured in vivo and in extract. The plotted values
correspond to the last two columns of Table 3. Continuous
line: best linear fit to the data. Dashed line: identity
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brain in vivo in glutamate, glutamine and aspartate, as
well as GABA and NAA with lower sensitivity. 13C
singlet linewidths of 6–8 Hz full-width at half-height
were significantly smaller than in most previous in vivo
studies performed in the rat brain. However, significant
overlap was still present between the different compo-
nents of a multiplet within a specific carbon resonance.
This spectral overlap resulted in a significant cross-
correlation between some of the isotopomer signals fitted
with LCModel. For example, cross-correlation between
Glu-C4S and Glu-C4D43 was typically 0.3, and the
cross-correlation between Glu-C3S and glu-C3T was
about 0.7, reflecting the overlap of the singlet with
the center line of the triplet (2 Hz chemical-shift differ-
ence at 150 MHz). The precision on the fit of the sum of
all isotopomers contributions to a specific carbon position
(e.g. C3SþC3DþC3T) was systematically better than the
precision of the fit of individual components (Fig. 5),
indicating that the sum of all isotopomers can be
measured reliably even when sensitivity does not allow
the precise quantitation of individual components of a
multiplet (Table 3). In cases where the signal-to-noise
ratio is not sufficient to measure low intensity isotopo-
mers, selective homonuclear 13C decoupling could be
applied to improve signal-to-noise ratio and spectral
resolution as shown in the intact perfused heart,49 by
collapsing, for example, the nine line glutamate C2
multiplet into a pseudo-triplet.
As pointed out previously, relative isotopomer concen-
trations are not a direct measure of the isotopic enrich-
ment.50 However, from the isotopomers, the isotopic
enrichment can be calculated. For example, the ratio
C4D43/(C4SþC4D43) is equal to the isotopic enrich-
ment of the C3 carbon position in glutamate and gluta-
mine (assuming no labeling at the C5 position). Similarly,
the isotopic enrichment of the C2 and C4, IEC2 and IEC4,
respectively, can be calculated from the C3 multiplet, as
follows: the probabilities of obtaining double and
triply labeled isotopomers are C3D¼ IEC2(1IEC4)þ
IEC4(1IEC2) and C3T¼ IEC2*IEC4 respectively, from
which IEC2*IEC4¼C3T and IEC2þIEC4¼C3Dþ2*C3T
can be obtained. These two equations with two un-
knowns, IEC2 and IEC4, can be solved, but the solutions
cannot be assigned unambiguously to either the C2 or the
C4 isotopic enrichment unless additional information is
obtained (e.g. which resonance has the highest total
signal). Such an in vivo measurement of 13C isotopic
enrichment is highly desirable in human studies, where
extracts cannot be obtained. Measurement of isotopic
enrichments in vivo normally requires the additional
acquisition of 1H–13C edited spectra, the quantitation of
which may be complicated by severe spectral overlap. In
addition, isotopic enrichments obtained from 1H–13C
NMR spectra may be biased by the presence of metabo-
lically inert pools.
The standard deviation of 13C concentrations measured
at isotopic steady state from a 400 ml volume was on
average 0.1mmol/g with 22 min time resolution (Table 3).
In the presence of spectral overlap, such as glutamate C2
and glutamine C2, the standard deviations were slightly
higher, reflecting the cross-correlation between overlap-
ping signals. The measured standard deviations confirm
that labeling time courses of glutamate (5 mmol/g of
label at isotopic steady state in this study) and glutamine
(2 mmol/g of label) can be measured reliably with a
temporal resolution as low as 5 min (standard deviation
0.2mmol/g), and aspartate (1.5mmol/g of label)
with a time resolution of 22 min (standard deviation
0.1mmol/g). This also implies that GABA time courses
(13C concentration 0.25 micromol/g at isotopic steady
state) can be obtained with a temporal resolution of 1 h,
which was confirmed experimentally (not shown).
Further improvements in the quantification of time series
of 13C spectra should be possible by taking into account
the common information present in all spectra of the time
series, similar to a recent study,21 provided that such an
Figure 8. Time courses of 13C label incorporation into
multiple carbon positions of glutamate and glutamine ob-
tained in vivo from a 400ml volume in the rat brain: (a)
Labeling time courses of glutamate C4, glutamate C3,
glutamine C4 and glutamine C3 with 5.4 min time resolu-
tion; (b) labeling time courses of glutamate C2, glutamine
C2 with 5.4 min time resolution and glutamate C1 with
22 min time resolution. The labeling curves for the C4, C3
and C2 positions were obtained by adding all isotopomer
signals at the corresponding carbon position (i.e. C4¼C4Sþ
C4D43, C3¼C3SþC3DþC3T and C2¼C2SþC2D23þ
C2D21þC2DD). The isotopic enrichment of glutamate C1
was obtained indirectly through isotopomers at the C2
position (C1¼C2D21þC2DD)
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approach accommodates small line shape and line width
changes that can occur in vivo.
The excellent sensitivity of 13C NMR spectra in our
study and the robustness of LCModel analysis to quantify
total 13C label at a given carbon position also predicted
that 13C labeling time courses for glutamate and gluta-
mine could be measured with excellent sensitivity from a
small volume. Consistent with this, time courses of 13C
label incorporation into glutamate and glutamine C4 and
C3 were measured in the rat somatosensory cortex
(8 2 3 mm) with a time resolution of 11 min (data
not shown). The signal-to-noise ratio of 13C NMR signals
from this 48ml volume was 8:1 and 3:1 for glutamate C4
and glutamine C4 at isotopic steady state. After quantita-
tion with LCModel, the standard deviation of total 13C
concentration at the glutamate and glutamine C4 and C3
carbon positions was approximately 0.4 mM at isotopic
steady-state, corresponding to a coefficient of variation of
8% for glutamate and 20% for glutamine. This demon-
strates the feasibility of measuring 13C labeling time
courses from small, localized areas of the rat brain using
direct 13C NMR spectroscopy.
Most metabolic studies have derived metabolic fluxes
in the brain based only on one or two 13C labeling time
courses e.g. glutamate C4 alone,51 glutamate C4 and
glutamate C334,52,53 or glutamate C4 and glutamine
C4.12,13 Recent studies have suggested that including
more information in the modeling of brain metabolism
provides results that depend on fewer assumptions.5,10,34
For example, it has been reported by several groups that the
exchange rate between 2-oxoglutarate and glutamate, Vx,
is low (on the order of the flux through pyruvate dehydro-
genase Vpdh) in the brain,
5,10,34 as it is in the heart54 and
liver.27 Therefore, the rate of label incorporation into the
C4 carbon position of glutamate alone may not be adequate
to measure Vpdh. Similarly, detection of the C2 labeling
can be used to estimate the anaplerotic flux through pyru-
vate carboxylase.5,7,55,56 In general, with increased infor-
mation and decreased assumptions used for the modeling,
metabolic fluxes can be determined more accurately.57
CONCLUSION
In conclusion, high-field localized 13C NMR spectro-
scopy combined with LCModel analysis permits us to
obtain in vivo a wealth of metabolic information hitherto
available only in extracts. This is expected to provide
novel information to measure quantitative metabolic
fluxes and further investigate compartmentalized meta-
bolism in the brain.
APPENDIX: ADAPTATIONS OF THE LCMODEL
PROGRAM TO ANALYZE 13C NMR SPECTRA
A modified version of LCModel v2.3 was necessary to
accommodate the larger number of points of 13C spectra
and the higher number of metabolites in the basis set
compared with 1H spectra. Specifically, LCModel 2.3
normally allows a maximum of 4096 complex points in
FIDs, a maximum spectral range of 2000 complex points
for the fit, and a maximum of 40 metabolites in the basis
set. The modified version accepted FIDs with up to 8192
complex points, allowed to fit a spectral range of 4000
complex points, and incorporated up to 60 metabolites in
the basis set.
In addition, several parameters provided in the CON-
TROL input file had to be modified, some of which are
not described in the documentation of LCModel:
* The knot spacing for the spline baseline function,
DKNTMN was set to the maximum value
(DKNTMN¼ 2*99) to impose a flat baseline in the fit.
* To prevent the pseudo-triplets from getting mistaken
for a single resonance in the estimation of the line
shape, the parameter NSIDMN that specifies the mini-
mum number of grid points on each side of the line-
shape (default value¼ 5) was reduced to 2.
* The estimated linewidth of the (simulated) basis spec-
tra, FWHMBA, was set to 0.049.
* One major difference between 1H and 13C spectra is
the 30 fold change in ppm range. The modifications
ALPBMN¼ 108, ALPBMX¼ 54000, ALPBPN¼
135, ALPBST¼ 162 reflect this difference in ppm
range. The proposed values of these parameters are
about (30)3 times their default 1H value. The 30-fold
increase in ppm range would require many additional
changes in the LCModel program unless the knot
spacing is fixed to a large value with DKNTMN and
phase parameters are set close to their optimal value
with DEGZER and DEGPPM.
* More freedom was given to LCModel to allow small
frequency shifts between the in vivo data and the basis
set by setting DESDSH to 0.01 (in ppm) rather than the
default 0.004 value used for 1H.
* Estimation of the lineshape was performed on the
glucose C1, glucose C6, glutamate C4S, glutamate
C4D43, NAA C6, specified by NUSE1 and CHUSE1.
Including the doublet (e.g. Glu-C4D43) together with
the singlet (e.g. Glu-C4S) minimized the occurrence of
errors in the line shape analysis caused by overlap
between the singlet and the doublet.
* The phase of the spectra was determined manually on
the sum of the entire time course (the phase was stable
over the entire time course) and starting values for
DEGZER and DEGPPM were entered (DEGZER¼
rp0.5*lp and DEGPPM¼lp/(spectral width in
ppm), where rp and lp are the Varian parameters for
zero and first order phase adjustment). Small degrees
of freedom were left to both zero and first order phase
by setting SDDEGZ¼ 3 and SDDEGP¼ 0.5.
* NCOMBI, CHCOMB: combination used to obtain the
sums of isotopomers at a given carbon position, e.g.
CHCOMB(1)¼ ‘‘gluC3þgluC34þglu324’’ gives the
410 P.-G. HENRY ET AL.
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total concentration and Cramer–Rao bound for total
glutamate C3.
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